essential medicines<br /><span>for children</span> development, licensing,<br /><span>commercialisation</span>  unmet health<br /><span>care needs</span>  age appropriate<br /><span>formats</span> licensed medicines<br /><span>for children</span>
essential medicines
for children
development, licensing,
commercialisation
unmet health
care needs
age appropriate
formats
licensed medicines
for children

Home

Proveca, established in 2010, focuses on the re-engineering of existing generic medicines to make them appropriate for use by young people, many of whom have chronic conditions requiring long term drug treatment.

Proveca was created to bring much needed licensed medicines to children (and adults) in Europe. Currently, 50-90% of the medicines children take are in the wrong format and/or are unlicensed. Using the recently introduced Paediatric Use Marketing Authorisation (PUMA) regulatory process we seek to provide children with the medicines they need in an appropriate format and with a valid licence throughout Europe.

Some of our paediatric development opportunities are also relevant to the adult market and where this is the case we will seek adult marketing authorisations. 

    • Proveca gains fourth key agreement with EMA

      read more...
    • Third key agreement reached with EMA

      read more...
    • Cheshire pharmaceutical firm enjoys strong start to first quarter

      read more...